Belite Bio Wins FDA Priority Review for Tinlarebant in Stargardt Disease

Prescription Drug User Fee Act target action date is February 12, 2027 If approved, tinlarebant would be the first-ever approved treatment for Stargar...

August 13, 2026 | Thursday | News
Leica Biosystems Secures FDA Clearances for AI-Assisted Pathology Quality Control and Digital Scanners

Leica Biosystems, a Danaher company and a global leader in end-to-end anatomic and digital pathology solutions, announced multiple U.S. Food and Drug Adm...

August 13, 2026 | Thursday | News
Revvity Launches SuperFlex Prenatal Screening System for Smaller Labs

Revvity’s new maternal and fetal biochemistry testing platform Designed for accessibility, simplicity, and flexibility Purpose-built for small...

August 13, 2026 | Thursday | News
PacBio Boosts Vega HiFi Sequencing Output by 50% with New SPRQ-Nx Chemistry

PacBio (NASDAQ: PACB), developer of the world’s most advanced sequencing technologies, announced the upcoming availability of SPRQ-Nx chemistry and...

August 13, 2026 | Thursday | News
SGPCR Institute Awards $6.7M to Advance Pancreatic Cancer Research

The Stephenson Global Pancreatic Cancer Research Institute (SGPCRI) announced the recipients of the 2026 Stephenson Global Scholar Grants. In partnership...

August 12, 2026 | Wednesday | News
QIAGEN Wins FDA Clearance for QIAstat-Dx Bloodstream Infection Panel

QIAstat-Dx BCID GPF Plus AMR Panel detects 20 pathogen targets and 10 antimicrobial resistance markers from positive blood cultures in about one hour...

August 12, 2026 | Wednesday | News
Fresenius Kabi Recalls Tyenne Injection Lot Over Glass Particle Contamination

Fresenius Kabi, an operating company of the Fresenius Group, is recalling one lot of Tyenne® (tocilizumab-aazg) Injection 400 mg/20 mL (20 mg/mL)20 m...

August 12, 2026 | Wednesday | News
Philips and Exor Update Long-Term Agreement, Raising Potential Stake to 22%

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Exor N.V. announced that they have agreed to update their long-term relat...

August 12, 2026 | Wednesday | News
Greenstone Biosciences Receives NIH Award to Advance AI-Driven Drug Discovery for DMD Cardiomyopathy

Award supports an iPSC and AI-driven drug discovery program targeting the leading cause of death in DMD patients Greenstone Biosciences, a biote...

August 10, 2026 | Monday | News
FDA Grants Accelerated Approval to Replimune’s Tudriqev for Advanced Melanoma

The U.S. Food and Drug Administration granted accelerated approval to Tudriqev (vusolimogene oderparepvec-wtpg), a genetically modified oncolytic viral t...

August 10, 2026 | Monday | News
Biogen Completes Acquisition of RayThera to Strengthen Immunology Pipeline

Biogen Inc. announced the completion of the acquisition of RayThera Inc., a privately held biotechnology company focused on discovering and developing sm...

August 10, 2026 | Monday | News
Bavarian Nordic Expands MVA-BN Approval to Children Aged 2 and Older in EU

MVA-BN approval expanded to include children aged 2 to less than 12 years for protection against mpox, smallpox and disease caused by vaccinia virus A...

August 10, 2026 | Monday | News
Bone Biologics Advances Targeted Bone Regeneration with the NELL-1 Platform

    Bone Biologics is developing a targeted approach to bone regeneration through its proprietary NELL-1 platform, designed to address the li...

August 10, 2026 | Monday | Interaction
Basilea Secures Additional BARDA Funding to Advance Oral Antibiotic for Complicated UTIs

Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bac...

August 06, 2026 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close